MARIE SCARLETTE RIVAS: Open Payments
NPI 1730572512 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,283 in 69 payments from 17 companies in 2025. Trend: 2023 $4,276 · 2024 $2,795 · 2025 $4,283
Food & beverage: $3,011Travel & lodging: $1,272
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 17 | $1,569 |
| Impulse Dynamics (USA) Inc. | 12 | $1,188 |
| AstraZeneca Pharmaceuticals LP | 11 | $297 |
| ABIOMED | 6 | $283 |
| Ancora Heart, Inc. | 1 | $164 |
| Alnylam Pharmaceuticals Inc. | 3 | $157 |
| Abbott Laboratories | 1 | $146 |
| SCPHARMACEUTICALS INC. | 2 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| PFIZER INC. | 3 | $62 |
Products named: Barostim Neo System, Optimizer, FARXIGA, AccuCinch, AMVUTTRA, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, FUROSCIX, Kerendia.
Industry payments across GA — which companies pay providers there.
